The Chemical GMP Synthesis Facility (CGSF) is a state-of-the-art manufacturing resource for small and large molecule therapeutics for clinical trials. It provides services for drug discovery, process research, and the development and early clinical manufacturing of active pharmaceutical ingredients (API) that meet the requirements of the Food and Drug Administration.

Thanks to its significant range of capabilities, the CGSF plays a key role in bridging basic science and translational medicine at City of Hope and is a key component of the Developmental Cancer Therapeutics Program.

The facility is designed specifically to produce quantities of API on scales suitable for use in preclinical toxicology studies and in Phase I and Phase II clinical trials.